Breaking News

Sharp Gets MHRA Approval for Clinical Services CoE

Can now offer a range of clinical and commercial services from the $12 million facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sharp, a global provider of contract packaging and clinical supply services, has received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to begin production at its Clinical Services Center of Excellence in Rhymney, Wales.   Following a successful inspection by the MHRA, Sharp can now offer a range of clinical trial and commercial services from the £9.5 million (~$12mn) facility including primary and secondary packaging with low humidity control, labelling, storage ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters